Foghorn Therapeutics Inc’s recently made public that its Chief People Officer Costa Carlos unloaded Company’s shares for reported $0.36 million on Sep 20 ’24. In the deal valued at $10.04 per share,35,756 shares were sold. As a result of this transaction, Costa Carlos now holds 0 shares worth roughly $0.0.
Then, Costa Carlos sold 857 shares, generating $8,716 in total proceeds. Upon selling the shares at $10.17, the Chief People Officer now owns 0 shares.
Before that, Costa Carlos sold 11,574 shares. Foghorn Therapeutics Inc shares valued at $116,319 were divested by the Chief People Officer at a price of $10.05 per share. As a result of the transaction, Costa Carlos now holds 0 shares, worth roughly $0.0.
Jefferies initiated its Foghorn Therapeutics Inc [FHTX] rating to a Buy in a research note published on September 03, 2024; the price target was $18. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who began to cover the stock in mid August with a ‘”an Outperform”‘ rating. BofA Securities began covering FHTX with “Buy” recommendation on March 28, 2023. BMO Capital Markets started covering the stock on January 05, 2023. It rated FHTX as “an Outperform”.
Price Performance Review of FHTX
On Friday, Foghorn Therapeutics Inc [NASDAQ:FHTX] saw its stock jump 2.62% to $4.31. Over the last five days, the stock has gained 0.23%. Foghorn Therapeutics Inc shares have fallen nearly -8.69% since the year began. Nevertheless, the stocks have fallen -15.66% over the past one year. While a 52-week high of $10.25 was reached on 01/06/25, a 52-week low of $2.70 was recorded on 01/14/25. SMA at 50 days reached $6.42, while 200 days put it at $6.70.
Levels Of Support And Resistance For FHTX Stock
The 24-hour chart illustrates a support level at 4.17, which if violated will result in even more drops to 4.02. On the upside, there is a resistance level at 4.45. A further resistance level may holdings at 4.58. The Relative Strength Index (RSI) on the 14-day chart is 31.80, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.24, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 83.49%. Stochastics %K at 14.37% indicates the stock is a buying.
How much short interest is there in Foghorn Therapeutics Inc?
A steep rise in short interest was recorded in Foghorn Therapeutics Inc stocks on 2024-12-31, dropping by -0.11 million shares to a total of 0.78 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 0.89 million shares. There was a decline of -14.31%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 22, 2021 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $25 price target.
